Systemic adjuvant therapy for high-risk cutaneous melanoma

Cutaneous melanoma continues to increase in incidence and poses a significant mortality risk. Surgical excision of melanoma in its early stages is often curative. However, patients with resected stages IIB-IV are considered at high risk for relapse and death from melanoma where systemic adjuvant the...

Descripción completa

Detalles Bibliográficos
Autores principales: Kobeissi, Iyad, Tarhini, Ahmad A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2022
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9619267/
https://www.ncbi.nlm.nih.gov/pubmed/36324735
http://dx.doi.org/10.1177/17588359221134087

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9619267/
https://www.ncbi.nlm.nih.gov/pubmed/36324735
http://dx.doi.org/10.1177/17588359221134087

Ejemplares similares